These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6403466)

  • 21. Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay.
    Findlow J; Holland A; Martin D; Oster P; Balmer P; Borrow R
    Clin Vaccine Immunol; 2007 May; 14(5):556-61. PubMed ID: 17344344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents.
    Nato F; Mazie JC; Fournier JM; Slizewicz B; Sagot N; Guibourdenche M; Postic D; Riou JY
    J Clin Microbiol; 1991 Jul; 29(7):1447-52. PubMed ID: 1909346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections.
    Raff HV; Devereux D; Shuford W; Abbott-Brown D; Maloney G
    J Infect Dis; 1988 Jan; 157(1):118-26. PubMed ID: 3121759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli.
    Cross AS; Zollinger W; Mandrell R; Gemski P; Sadoff J
    J Infect Dis; 1983 Jan; 147(1):68-76. PubMed ID: 6401788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human IgA1 initiates complement-mediated killing of Neisseria meningitidis.
    Jarvis GA; Griffiss JM
    J Immunol; 1989 Sep; 143(5):1703-9. PubMed ID: 2474610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.
    Zollinger WD; Mandrell RE; Griffiss JM; Altieri P; Berman S
    J Clin Invest; 1979 May; 63(5):836-48. PubMed ID: 109466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avidity of IgG antibodies against meningococcal serogroup a polysaccharide and correlations with bactericidal activity in sera from meningitis patients and controls from Ethiopia.
    Medhane M; Tunheim G; Naess LM; Mihret W; Bedru A; Norheim G; Petros B; Aseffa A; Rosenqvist E
    Scand J Immunol; 2014 Apr; 79(4):267-75. PubMed ID: 24383864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response of infants and children to disseminated infections with Neisseria meningitidis.
    Griffiss JM; Brandt BL; Broud DD; Goroff DK; Baker CJ
    J Infect Dis; 1984 Jul; 150(1):71-9. PubMed ID: 6431015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective immunization against group B meningococci using anti-idiotypic mimics of the capsular polysaccharide.
    Beninati C; Arseni S; Mancuso G; Magliani W; Conti S; Midiri A; Biondo C; Polonelli L; Teti G
    J Immunol; 2004 Feb; 172(4):2461-8. PubMed ID: 14764718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Michaelsen TE; Aase A; Käyhty H
    Infect Immun; 2005 Aug; 73(8):4694-703. PubMed ID: 16040982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of meningococcal group B vaccine candidates: capsular or noncapsular?
    Diaz Romero J; Outschoorn IM
    Clin Microbiol Rev; 1994 Oct; 7(4):559-75. PubMed ID: 7834605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
    Fischer M; Carlone GM; Holst J; Williams D; Stephens DS; Perkins BA
    Vaccine; 1999 May; 17(19):2377-83. PubMed ID: 10392619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.
    Azmi FH; Lucas AH; Raff HV; Granoff DM
    Infect Immun; 1994 May; 62(5):1776-86. PubMed ID: 8168940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity.
    Welsch JA; Moe GR; Rossi R; Adu-Bobie J; Rappuoli R; Granoff DM
    J Infect Dis; 2003 Dec; 188(11):1730-40. PubMed ID: 14639545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of low-avidity antibody by infants after infection with serogroup B meningococci.
    Pollard AJ; Levin M
    Lancet; 2000 Dec; 356(9247):2065-6. PubMed ID: 11145494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide.
    Bartoloni A; Norelli F; Ceccarini C; Rappuoli R; Costantino P
    Vaccine; 1995 Apr; 13(5):463-70. PubMed ID: 7543714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of the immune response to a modified group B meningococcal polysaccharide conjugate vaccine.
    Moore S; Farley EK; Fusco PC; Michon F
    Clin Vaccine Immunol; 2007 Jan; 14(1):106-9. PubMed ID: 17079431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of a protective epitope reveals the importance of acetylation of
    Henriques P; Dello Iacono L; Gimeno A; Biolchi A; Romano MR; Arda A; Bernardes GJL; Jimenez-Barbero J; Berti F; Rappuoli R; Adamo R
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29795-29802. PubMed ID: 33158970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine monoclonal antibodies for detection of antigens and culture identification of Neisseria meningitidis group B and Escherichia coli K-1.
    Krambovitis E; McIllmurray MB; Lock PA; Holzel H; Lifely MR; Moreno C
    J Clin Microbiol; 1987 Sep; 25(9):1641-4. PubMed ID: 3116036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.